£555k
+69%vs Nov 2024Active13729940Private limited companyBolton
REFINE PHARMA LTD
A81/10001
Summary
REFINE PHARMA LTD is an active private limited company (company number 13729940) incorporated on 8 November 2021, registered in Bolton. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest abridged accounts cover the period ending 30 November 2025, showing net assets of £555k and cash of £291k, with 9 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 69% on the prior period (£329k). Across the last 3 periods on record the net-asset trend is rising.
Peer position · net assets
By net assets it sits in the top quarter of 307 comparable companies in the UK (median £1,000, upper quartile £146k).
02
Key dates
- Incorporated
- 8 November 20214 yrs ago
- Next accounts due
- 30 August 2027in 312 days
- Confirmation statement due
- 22 November 2026in 31 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
04
Financials
£291k
−23%vs Nov 2024Not disclosed
9
No changevs Nov 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | £555k | £291k | £508k | £2.35m | — | — | 9 |
| 30 November 2024 | £329k | £379k | £157k | £1.56m | — | — | 9 |
| 30 November 2023 | £193k | £169k | £88k | £1.94m | — | — | 7 |
Current ratio1.23Current assets ÷ creditors within one year
Cash per employee£32kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
05
Firmoscan score
81 / 100 · grade A
| 50 | Starting scoreEvery scored company starts here |
| +10 | Positive net assetsNet assets £554,533 at 2025-11-30 |
| +8 | Net assets growing+68.7% vs prior period |
| +4 | Cash reservesCash £291,225 |
| +5 | Multi-year filing history3 periods on record |
| +4 | Past first filingsIncorporated 2021-11-08 |
| 81 | Score, grade A |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Refine Group Holdings Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Jarnail Singh Kang
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr Bradley Tyson
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Next accounts duein 312 days
- Confirmation statement duein 31 days
- Accounts period endNet assets £555k · abridged accounts
- Accounts period endNet assets £329k · abridged accounts
- Accounts period endNet assets £193k · abridged accounts
- Incorporated
08
Similar companies in Manchester
- EP MEDICAL GROUP LTDAltrincham · inc. Dec 2021
- PHARMACEUTICAL TECHNOLOGY CENTRE LTDWarrington · inc. Sept 2022
- SPECTRUMX DIRECT LIMITEDKnutsford · inc. Nov 2020
- MOVE IT TO CLOUD LIMITEDMacclesfield · inc. Jan 2023
- TROPHICELL LTDWigan · inc. May 2023
- NIHADAHMED LTDRochdale · inc. Aug 2023
All companies incorporated on 8 November 2021 · in Nov 2021.
09
Reminders for REFINE PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.